Last reviewed · How we verify
Otitis media caused by Moraxella (Branhamella) catarrhalis
Approved treatments
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Otitis media caused by Moraxella (Branhamella) catarrhalis patent landscape — cliff calendar, originator estates, attackable patents
- Otitis media caused by Moraxella (Branhamella) catarrhalis treatment landscape brief
- Otitis media caused by Moraxella (Branhamella) catarrhalis treatment updates RSS
Frequently asked questions about Otitis media caused by Moraxella (Branhamella) catarrhalis
What drugs treat Otitis media caused by Moraxella (Branhamella) catarrhalis?
Tracked treatments include Levaquin.
What is the treatment for Otitis media caused by Moraxella (Branhamella) catarrhalis?
Standard treatment for Otitis media caused by Moraxella (Branhamella) catarrhalis includes Levaquin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Otitis media caused by Moraxella (Branhamella) catarrhalis patent cliff · Otitis media caused by Moraxella (Branhamella) catarrhalis CI report
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing